TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Laurus Labs Ltd. ( (IN:LAURUSLABS) ) just unveiled an update.
Laurus Labs Ltd. held its 20th Annual General Meeting (AGM) on June 26, 2025, conducted through video conferencing with e-voting facilitated by NSDL. The scrutinizer’s report, prepared by Y. Ravi Prasada Reddy, confirmed the participation of 1,433 members in the voting process, highlighting the company’s commitment to transparency and shareholder engagement.
More about Laurus Labs Ltd.
Laurus Labs Ltd. operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of active pharmaceutical ingredients, generic formulations, and biotechnology products. The company is committed to providing high-quality and affordable medicines, primarily catering to the needs of the global healthcare sector.
Average Trading Volume: 77,609
Current Market Cap: 361.2B INR
For detailed information about LAURUSLABS stock, go to TipRanks’ Stock Analysis page.